Kaposi's sarcoma in a hospital setting in Lomé(Togo): A study of 93 cases

International Journal of Dermatology

Volumn 46, Issue SUPPL. 1, 2007, Pages 42-44

  Pitche, Palokinam T ^a,b   Kombate, Koussaké ^a   Owono, Françoise ^a   Tchangai Walla, Kissem ^a  

^a University of Lomé ^*  (Togo)

^b UNIVERSITY OF LOMÉ   (Togo)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ANTIRETROVIRUS AGENT; VINBLASTINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; DISEASE ASSOCIATION; FEMALE; HEALTH CARE ACCESS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; INCIDENCE; KAPOSI SARCOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MONOTHERAPY; MORTALITY; SERODIAGNOSIS; TOGO; UNIVERSITY HOSPITAL;

ADULT; AGED; FEMALE; HIV; HIV INFECTIONS; HOSPITALS, UNIVERSITY; HUMANS; LOWER EXTREMITY; MALE; MIDDLE AGED; MOUTH NEOPLASMS; SARCOMA, KAPOSI; SKIN NEOPLASMS; SURVIVAL RATE; TOGO;

EID: 35148874799     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2007.03464.x     Document Type: Article

References (15)

1. Antman K, Chang Y. Kaposi's sarcoma. N Engl J Med 2000; 342: 1027-1038.
2. Kaminer B, Murray JF. Sarcoma idiopathicum multiplex heamorrfagicum of Kaposi, with special reference to its incidence in the South African Negro, and two cases report. S Afr J Clin Sci 1950; 1: 1-25.
3. Hira SK, Wadhawan D, Kamanga J, et al. Cutaneous manifestations of human immunodeficiency virus in Lusaka, Zambia. J Am Acad Dermatol 1988; 19: 451-457.
4. Onyango JF, Njiru A. Kaposi's sarcoma in a Nairobi hospital. East Afr Med J 2004; 3: 120-123.
5. Chang Y, Cesarman E, Pressin MS, et al. Identification of herpes virus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994; 266: 1865-1869.
6. Wamburu G, Masenga EJ, Moshi EZ, et al. HIV-associated and non-HIV-associated types of Kaposi's sarcoma in an African population in Tanzania. Status of immune suppression and HHV-8 seroprevalence. Eur J Dermatol 2006; 16: 677-682.
7. Jacobson L, Yamashita T, Derels R, et al. Impact of potent antiretroviral therapy on the incidence of Kaposi's sarcoma and non-Hodgkin's lymphoma among HIV-1 infected individuals. J Acquir Immune Defic Syndr 1999; 21: S34-S41.
8. Ives N, Gazzard B, Easterbrook P. The changing pattern of AIDS-defining illness with the introduction of highly active antiretroviral therapy (HAART) in a London clinic. J Infect Dis 2001; 42: 134-139.
9. Onunu AN, Okoduwa C, Eze EU, et al. Kaposi's sarcoma in Nigeria. Int J Dermatol 2007; 46: 264-267.
10. Ebrahim SH, Abdullah AS, Mckenna M, et al. AIDS-defining cancers in Western Europe, 1994-2001. AIDS Patient Care STDS 2004; 18: 501-508.
11. Engels EA, Biggar RJ, Marshall VA, et al. Detection and quantification of sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma. AIDS 2003; 16: 1847-1851.
12. Duprez R, Kassa-Kelembo E, Plancoulaine S, et al. Human herpesvirus 8 serological markers and viral load in patients with AIDS-associated Kaposi's sarcoma in the Central African Republic. J Clin Microbiol 2005; 43: 4840-4843.
13. Malope BI, Pfeiffer RM, Mbisa G, et al. Transmission of Kaposi sarcoma-associated herpesvirus between mothers and children in a South African population. J Acquir Immune Defic Syndr 2007; 44: 351-355.
14. Newton R, Ziegler J, Bourboulia D, et al. Infection with Kaposi's sarcoma-associated herpesvirus and human immunodeficiency virus in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda. Br J Cancer 2003; 89: 502-504.
15. Stebbing J, Sanitt A, Teague A, et al. Prognostic significance of immune subset measurement in individuals with AIDS Kaposi's sarcoma. J Clin Oncol 2007; 25: 2230-2235.